The effects of E2 and selective agonists of ER subtypes on leptin-related intracellular signaling pathways were investigated to understand potential mechanisms of estrogenic protection in leptin-induced HepG2 cell growth and thus obesity-related HCC. This evidence concerns the gene LEP and hepatocellular carcinoma.